Compare FELE & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FELE | ALKS |
|---|---|---|
| Founded | 1944 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.5B |
| IPO Year | 1995 | 2012 |
| Metric | FELE | ALKS |
|---|---|---|
| Price | $89.80 | $28.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 14 |
| Target Price | ★ $103.50 | $43.43 |
| AVG Volume (30 Days) | 280.4K | ★ 1.9M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.23% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.22 | 1.43 |
| Revenue | ★ $2,131,250,000.00 | $1,475,899,000.00 |
| Revenue This Year | $5.95 | $24.06 |
| Revenue Next Year | $3.94 | $4.53 |
| P/E Ratio | $28.37 | ★ $19.86 |
| Revenue Growth | ★ 5.44 | N/A |
| 52 Week Low | $78.88 | $25.17 |
| 52 Week High | $111.53 | $36.32 |
| Indicator | FELE | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 32.09 | 39.31 |
| Support Level | $84.31 | $27.48 |
| Resistance Level | $98.40 | $28.75 |
| Average True Range (ATR) | 2.43 | 0.91 |
| MACD | -0.50 | 0.01 |
| Stochastic Oscillator | 1.87 | 34.88 |
Franklin Electric Co Inc designs, manufactures, and distributes water and fuel pumping systems, composed of submersible motors, pumps, electronic controls, water treatment systems, and related parts and equipment. It has three segments; The Water Systems segment designs, manufactures and sells motors, pumps, drives, electronic controls, monitoring devices, and related parts and equipment for use in groundwater, water transfer, and wastewater, The Energy Systems segment designs, manufactures and sells pumps, pipe, sumps, fittings, vapor recovery components, electronic controls, monitoring devices, and related parts and equipment for use in fueling system applications and the Distribution segment sells and provides presale support and specifications to the installing contractors.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.